In this podcast episode, we had the pleasure of hosting Fabrizio Maniglio, an industry Business Development Director at Honeywell with a wealth of experience in Quality and Supply Chain Management within the life sciences sector. His insights into AI's transformative impact in the healthcare and pharmaceutical industries promise to make this conversation both enlightening and engaging. ------------------------------------------------------ The podcast is brought to you by ⁠Qualistery⁠, a leading provider of webinars, training, and consulting for the pharma industry. For business inquiries, get in touch at [email protected]. ------------------------------------------------------ Podcast Overview: The podcast episode features Fabrizio Maniglio, an experienced QA leader in the life sciences sector He discusses the future of AI in pharmaceuticals and the importance of digitalization and connected data The potential applications of AI in risk management and decision-making in the industry are highlighted The FDA is moving towards a risk management validation approach for AI in regulated spaces The discussion emphasizes the need for the pharma industry to drive change and not rely solely on regulators Companies are encouraged to experiment with AI technologies in low-stakes scenarios and use AI as a tool to solve specific problems The importance of staying current with AI trends and technology is emphasized, with recommendations for following the speaker on social media for more information on AI and potential future webinars.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related